Michael Brian Bell - 15 Mar 2024 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Financial Officer
Signature
/s/ John G. Saia, as attorney-in-fact for Michael Brian Bell
Issuer symbol
GH
Transactions as of
15 Mar 2024
Net transactions value
-$7,610
Form type
4
Filing time
18 Mar 2024, 18:12:41 UTC
Previous filing
16 Jan 2024
Next filing
17 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +1,233 +11% $0.000000 12,882 15 Mar 2024 Direct
transaction GH Common Stock Tax liability $7,610 -429 -3.3% $17.74 12,453 15 Mar 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -1,233 -11% $0.000000 9,864 15 Mar 2024 Common Stock 1,233 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This represents a restricted stock unit award granted on May 9, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on March 15, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
F3 Not applicable for Restricted Stock Units.